You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 123 No. 12, December 1987 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  36TH ANNUAL SYMPOSIUM ON THE BIOLOGY OF SKIN
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (86)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Skin as the Site of Vitamin D Synthesis and Target Tissue for 1,25-Dihydroxyvitamin D3

Use of Calcitriol (1,25-Dihydroxyvitamin D3) for Treatment of Psoriasis

Michael F. Holick, PhD, MD; Ellen Smith, PhD; Stephanie Pincus, MD

Arch Dermatol. 1987;123(12):1677-1683a.


Abstract



• Vitamin D is a hormone, not a vitamin. The skin is responsible for producing vitamin D. During exposure to sunlight, ultraviolet radiation penetrates into the epidermis and photolyzes provitamin D3 to previtamin D3. Previtamin D3 can either isomerize to vitamin D3 or be photolyzed to lymisterol and tachysterol. Vitamin D is also sensitive to sunlight and is photolyzed to 5,6-transvitamin D3, suprasterol I, and suprasterol II. In Boston, solar irradiation only produces previtamin D3 in the skin between the months of March and October. Aging, sunscreens, and melanin all diminish the capacity of the skin to produce previtamin D3. Once formed, vitamin D3 enters the circulation and is sequentially metabolized to 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 (1,25-[OH]2-D3). The epidermis possesses receptors for 1,25-(OH)2-D3.1,25-(OH)2-D3D3 inhibits the proliferation of cultured keratinocytes and induces them to terminally differentiate. The topical or oral administration of 1,25-(OH)2-D3 has proved to be effective for the treatment of psoriasis. Therefore, the skin is the site for the synthesis of vitamin D and a target tissue for its active metabolite. The successful use of 1,25-(OH)2-D3 for the treatment of psoriasis heralds a new approach for the treatment of this enigmatic disorder.

(Arch Dermatol 1987;123:1677-1683a)



Author Affiliations



From the US Department of Agriculture/Human Nutrition Research Center and Department of Physiology, Tufts University (Drs Holick and Smith), and Department of Dermatology, New England Medical Center (Dr Pincus), Boston. Dr Holick is now with Boston University Medical School.


Footnotes



Accepted for publication May 21, 1987.

Read before the 36th Annual Symposium on the Biology of Skin ("Molecular Basis of Nutritional Dermatoses"), Salishan Lodge, Gleneden Beach, Ore, Oct 20, 1986.

Reprint requests to Boston University Medical School, Bldg M, Rm 1013, 80 E Concord St, Boston, MA 02118 (Dr Holick).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Geographic variations of multiple sclerosis in France
Fromont et al.
Brain 2010;133:1889-1899.
ABSTRACT | FULL TEXT  

Timing of birth and risk of multiple sclerosis: population based study
Willer et al.
BMJ 2005;330:120.
ABSTRACT | FULL TEXT  

Impetigo Herpetiformis Associated With Hypocalcemia of Congenital Rickets
Holm and Goldsmith
Arch Dermatol 1991;127:91-95.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.